Clover Health Investments (CLOV) Competitors $2.58 -0.02 (-0.58%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$2.58 0.00 (0.00%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLOV vs. ACT, OSCR, BWIN, FG, PLMR, GSHD, HGTY, NMIH, LMND, and BHFShould you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Enact (ACT), Oscar Health (OSCR), Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Palomar (PLMR), Goosehead Insurance (GSHD), Hagerty (HGTY), NMI (NMIH), Lemonade (LMND), and Brighthouse Financial (BHF). These companies are all part of the "insurance" industry. Clover Health Investments vs. Its Competitors Enact Oscar Health Baldwin Insurance Group F&G Annuities & Life Palomar Goosehead Insurance Hagerty NMI Lemonade Brighthouse Financial Clover Health Investments (NASDAQ:CLOV) and Enact (NASDAQ:ACT) are both insurance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability. Which has more volatility & risk, CLOV or ACT? Clover Health Investments has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, Enact has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Which has better earnings and valuation, CLOV or ACT? Enact has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Enact, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClover Health Investments$1.37B0.96-$43.01M-$0.05-51.50Enact$1.20B4.72$688.07M$4.448.51 Do institutionals & insiders believe in CLOV or ACT? 19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 18.0% of Enact shares are held by institutional investors. 24.1% of Clover Health Investments shares are held by insiders. Comparatively, 0.4% of Enact shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor CLOV or ACT? In the previous week, Enact had 4 more articles in the media than Clover Health Investments. MarketBeat recorded 9 mentions for Enact and 5 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.57 beat Enact's score of -0.02 indicating that Clover Health Investments is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enact 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is CLOV or ACT more profitable? Enact has a net margin of 56.93% compared to Clover Health Investments' net margin of -1.69%. Enact's return on equity of 14.44% beat Clover Health Investments' return on equity.Company Net Margins Return on Equity Return on Assets Clover Health Investments-1.69% -7.42% -4.00% Enact 56.93%14.44%11.01% Do analysts prefer CLOV or ACT? Clover Health Investments currently has a consensus price target of $4.83, indicating a potential upside of 87.70%. Given Clover Health Investments' stronger consensus rating and higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Enact.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clover Health Investments 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Enact 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryClover Health Investments and Enact tied by winning 8 of the 16 factors compared between the two stocks. Get Clover Health Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLOV vs. The Competition Export to ExcelMetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.30B$2.04B$5.55B$9.05BDividend YieldN/AN/A5.24%4.01%P/E Ratio-51.5016.6019.5920.21Price / Sales0.9615.98418.25119.02Price / CashN/A55.8836.8958.10Price / Book3.798.708.035.67Net Income-$43.01M-$62.39M$3.18B$249.21M7 Day Performance-6.70%2.58%2.93%3.28%1 Month Performance-14.74%3.01%3.75%5.55%1 Year Performance102.76%4.06%35.20%21.09% Clover Health Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLOVClover Health Investments2.2408 of 5 stars$2.58-0.6%$4.83+87.7%+106.0%$1.30B$1.37B-51.50680News CoverageACTEnactN/A$37.15+1.0%$35.00-5.8%+22.5%$5.58B$1.20B8.37500Trending NewsOSCROscar Health1.4623 of 5 stars$21.53+5.5%$16.50-23.4%-3.2%$5.48B$9.18B76.892,400Trending NewsAnalyst ForecastGap UpHigh Trading VolumeBWINBaldwin Insurance Group2.2783 of 5 stars$42.81+0.3%$44.83+4.7%+12.9%$5.07B$1.39B-82.334,116Positive NewsFGF&G Annuities & Life4.1706 of 5 stars$31.94-0.6%$44.33+38.8%-15.3%$4.30B$5.74B8.471,338PLMRPalomar3.7167 of 5 stars$154.25+0.6%$174.17+12.9%+77.6%$4.12B$553.86M30.79150Analyst DowngradeGSHDGoosehead Insurance4.2292 of 5 stars$105.51+3.0%$115.40+9.4%+83.8%$3.96B$314.51M88.661,580HGTYHagerty1.1199 of 5 stars$10.09-0.9%$10.50+4.1%-7.7%$3.45B$1.20B50.451,744Insider TradeNMIHNMI1.9969 of 5 stars$42.19flat$42.29+0.2%+26.0%$3.30B$650.97M9.11234LMNDLemonade2.348 of 5 stars$43.88+4.3%$28.17-35.8%+160.9%$3.22B$526.50M-14.431,235Analyst ForecastBHFBrighthouse Financial4.7112 of 5 stars$53.77-1.2%$60.80+13.1%+19.5%$3.09B$6.69B6.451,400News CoverageAnalyst Forecast Related Companies and Tools Related Companies Enact Alternatives Oscar Health Alternatives Baldwin Insurance Group Alternatives F&G Annuities & Life Alternatives Palomar Alternatives Goosehead Insurance Alternatives Hagerty Alternatives NMI Alternatives Lemonade Alternatives Brighthouse Financial Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLOV) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
